Glutamine Powder Induced Hepatotoxicity: It Is Time to Understand the Side Effects of Sports Nutritional Supplements
Gastroenterology and Hepatology from Bed to Bench,
Vol. 13 No. 1 (2020),
22 Bahman 2020
,
Page 86-89
https://doi.org/10.22037/ghfbb.v13i1.1791
Abstract
Glutamine has been considered as a dietary supplement with a non-essential amino acid structure. Some studies found that liver failure may be associated with a high plasma glutamine level. Consumption of this product may be associated with potential adverse effect. This report describe the first case of glutamine induced hepatotoxicity. A 35-year-old female athlete with severe abdominal pain and scleral icterus was referred to the hospital. She has been taking glutamine powder for the past three weeks ago. Impaired liver function test and imaging evaluation suggested hepatotoxicity. Glutamine consumption was discontinued and the patient was closely monitored. Finally, after two weeks, the patient recovered successfully. This novel case was the first report regarding glutamine induced hepatotoxicity. Health care providers must know that consumption of dietary supplement such as glutamine may be associated with serious side effects. Liver damage is a possible side effect of glutamine. Hence it is necessary to consider hepatotoxicity as an adverse reaction in case of glutamine supplement consumption.
- Glutamine
- Hepatotoxicity
- Side effects
- Pharmacovigilance
- Supplements
How to Cite
References
Ahmad J, Odin JA. Epidemiology and Genetic Risk Factors of Drug Hepatotoxicity. Clin Liver Dis 2017; 21:55-72.
Navarro V, Khan I, Björnsson E, Seeff LB, Serrano J, Hoofnagle JH. Liver Injury from Herbal and Dietary Supplements. Hepatology (Baltimore, Md.) 2017; 65:363-373.
Knapik JJ, Steelman RA, Hoedebecke SS, Austin KG, Farina EK, Lieberman HR. Prevalence of Dietary Supplement Use by Athletes: Systematic Review and Meta-Analysis. Sports Medicine (Auckland, N.z.) 2016; 46:103-123.
Thomas DT, Erdman KA, Burke LM. Position of the Academy of Nutrition and Dietetics, Dietitians of Canada, and the American College of Sports Medicine: Nutrition and Athletic Performance. J Acad Nutr Diet 2016; 116:501-528.
Williams MH. Dietary Supplements and Sports Performance: Introduction and Vitamins. Journal of the International Society of Sports Nutrition 2004; 1:1-6.
Williams M. Dietary Supplements and Sports Performance: Amino Acids. Journal of the International Society of Sports Nutrition 2005; 2:63-67.
Suzic Lazic J, Dikic N, Radivojevic N, Mazic S, Radovanovic D, Mitrovic N, et al. Dietary supplements and medications in elite sport--polypharmacy or real need? Scand J Med Sci Sports 2011; 21:260-267.
Kamangar F, Emadi A. Vitamin and Mineral Supplements: Do We Really Need Them? International Journal of Preventive Medicine 2012; 3:221-226.
Mousavi S, Mansouri A, Jahangard-Rafsanjani Z, Sarayani A, Hadjibabaie M, Gholami K. Bibliographic search of publication patterns in rational use of drugs in Iran: a systematic approach. Acta Medica Iranica 2014; 6.
Danan G, Teschke R. RUCAM in Drug and Herb Induced Liver Injury: The Update. International Journal of Molecular Sciences 2016; 17:14.
Huang Y-S. S1881 The Therapeutic Efficacy of Ursodeoxycholic Acid (UDCA) in Drug-Induced Liver Injury: Results of a Randomized Controlled Trial. Gastroenterology 2010; 138:S-809.
Nabi T, Nabi S, Rafiq N, Shah A. Role of N-acetylcysteine treatment in non-acetaminophen-induced acute liver failure: A prospective study. Saudi Journal of Gastroenterology : Official Journal of the Saudi Gastroenterology Association 2017; 23:169-175.
Newsholme P, Procopio J, Lima MM, Pithon-Curi TC, Curi R. Glutamine and glutamate--their central role in cell metabolism and function. Cell Biochem Funct 2003; 21:1-9.
McCormack WP, Hoffman JR, Pruna GJ, Jajtner AR, Townsend JR, Stout JR, et al. Effects of l-Alanyl-l-Glutamine Ingestion on One-Hour Run Performance. J Am Coll Nutr 2015; 34:488-496.
Helling G, Wahlin S, Smedberg M, Pettersson L, Tjader I, Norberg A, et al. Plasma Glutamine Concentrations in Liver Failure. PLoS One 2016; 11:e0150440.
Bismuth M, Funakoshi N, Cadranel JF, Blanc P. Hepatic encephalopathy: from pathophysiology to therapeutic management. Eur J Gastroenterol Hepatol 2011; 23:8-22.
Nazari MA, Malayeri SH, Pourhoseingholi MA, Mohebi SR, Zali MR. Evaluation of Zinc Plasma Level in Iranian Cirrhotic Patients due to Hepatitis B and Hepatitis C. Hepatitis Monthly 2010; 10:62-64.
- Abstract Viewed: 189 times
- PDF Downloaded: 51 times